No description
-
2014 (v1)PublicationUploaded on: May 13, 2023
-
2022 (v1)Publication
BACKGROUND: Psoriatic arthritis (PsA) is an inflammatory condition which can affect up to 41% of psoriatic patients [1]. In 40-60% of pa-tients, PsA can determine cartilage destruction and joint deformities, hereby heavily impacting physical function and quality of life, even increas-ing the risk of death compared to the general population [1]....
Uploaded on: February 6, 2024 -
2020 (v1)Publication
Introduction: Biologics have revolutionized the therapy of moderate-to-severe plaque psoriasis. Yet, despite their greater efficacy over conventional systemic therapies their high cost has represented a burden for healthcare systems, which limited their use. More recently, the availability of several biosimilars at low cost is changing the...
Uploaded on: April 14, 2023